Shkreli Seeks Early Prison Release to Help With Covid ‘Cure’
- Lawyers: one company is ready to begin trials on his work
- ‘Pharma Bro’ is currently scheduled for October 2023 release
This article is for subscribers only.
Martin Shkreli asked a federal judge to release him early from prison, saying he “has been conducting significant research into developing molecules to inhibit the coronavirus” and would continue doing so if set free.
Shkreli, who is scheduled to be released in October 2023, says he suffers from asthma and allergies which make him susceptible to contracting Covid-19 if he remains in prison. He was sentenced in March 2018 to seven years after being convicted of securities fraud for lying to investors in his hedge funds and manipulating shares in Retrophin Inc., a biotech company he founded.